NLRP3 and COVID-19: In addition, NLRP3 inflammasome and related proinflammatory cytokines also play an important role in coronavirus disease 2019 (COVID-19)-associated ALI/ARDS, showing potential of targeting NLRP3 inflammasome in treatment (11–14).